Novotech Wins CRO Contract for Covid-19 Clinical Trial in South Korea

Asia-Pacific’s largest specialist biotech CRO Novotech has been selected for the Komipharm International clin...

March 9, 2020 | Monday | News
WuXi Biologics congratulates Immutep on positive interim data for IMP-321

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...

February 24, 2020 | Monday | News
AVROBIO announces clinical and regulatory progress for Gaucher Disease Program

US based AVROBIO, a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic...

January 17, 2020 | Friday | News
PPD expands clinical capabilities in China

PPD, Inc. ( PPD ) has expanded its China operations and leadership team to provide more international and Chin...

January 15, 2020 | Wednesday | News
Genome & Company inks clinical trial collaboration

Genome & Company, a clinical-stage biotechnology company based in Seongnam, Republic of Korea, has announced th...

January 15, 2020 | Wednesday | News
Hummingbird Publishes Preclinical efficacy of HMBD-001 in HER3 driven Cancers

Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery and development of new breakthrou...

January 8, 2020 | Wednesday | News
CStone initiates CS1001 trial to treat ESCC in China

CStone Pharmaceuticals has announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Co...

January 8, 2020 | Wednesday | News
Transgene, NEC initiate trials with AI-Powered Cancer Vaccine

French firm Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of canc...

January 7, 2020 | Tuesday | News
Eisai presented research data on Eribulin (Halaven) at 42nd Annual SABCS2019

Eisai Co., Ltd. presented its latest information on its in-house discovered and developed eribulin mesylate (halich...

December 16, 2019 | Monday | News
Gracell to Present at the 38th Annual J.P. Morgan Healthcare Conference

Gracell Biotechnologies Co. Ltd., a clinical-stage immune cell therapy company, has announced it will present at leading...

December 31, 2019 | Tuesday | News
Roche’s Ph III cancer immunotherapy trial reveals positive results for liver cancer

Liver cancer is the fourth most common cancer among men and affects approximately 24 individuals in every 100,000 people...

December 18, 2019 | Wednesday | News
NeuClone announces Positive Ph I results of Herceptin® (Trastuzumab) Biosimilar

NeuClone Pharmaceuticals Ltd, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality ...

December 13, 2019 | Friday | News
Takeda presents Phase III Trial results in patients with amyloidosis

Japan based Takeda Pharmaceutical Company Limited announced the presentation of the results of tourmaline-AL1 trial in a...

December 9, 2019 | Monday | News
CASI Pharma gets China approval Of CNCT19 Clinical Trial Applications

CASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing innovative therap...

December 4, 2019 | Wednesday | News
Seattle Genetics, Astellas announce Clinical Trial collaboration with Merck

Seattle Genetics, Inc. and Astellas Pharma Inc.have announced a clinical collaboration agreement with Merck, k...

December 3, 2019 | Tuesday | News
Combination of Immunotherapy and VEGF Inhibitor Improves Survival in HCC

Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves over...

November 22, 2019 | Friday | News
Trastuzumab Biosimilar HLX02 Met Primary Endpoint in Breast Cancer

The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epi...

November 22, 2019 | Friday | News
CStone announces first patient dosed in the Phase I study of ivosidenib

CStone Pharmaceuticals on 20 Nov 2019 announced that the first patient has been dosed in Phase I bridging the registrati...

November 20, 2019 | Wednesday | News